IP Library › Granted Patent US 12,471,927
Granted Patent B2
US 12,471,927 · App. 18/530,500 · Granted Nov 18, 2025

Device for restricting blood flow to aneurysms

Inventors: Danel Mayer (Tel Aviv, IL); Alon May (Caesarea, IL)
Assignee: ENDOSTREAM MEDICAL LTD.
A61B17/12113A61B17/12036A61B17/1214A61B17/12145A61B17/12172A61B2017/00526A61B2017/22042A61F2002/016
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,471,927
App. No.
18/530,500
Granted
Nov 18, 2025
Kind
B2
Abstract

A non-occlusive blood restricting device is provided for delivery by a microcatheter and for treating a vascular malformation. The blood restricting device includes a wire that include first and second sections. The first section is configured to be coiled into a first coil when deployed within the vascular malformation. The first coil includes a spiral or sequence of loops, the spiral or sequence of loops having a gradually decreasing diameter. The first coil is configured to line a neck, a wall, or the neck and the wall of the vascular malformation so as to at least partially cover an orifice of the vascular malformation. The second section is configured to be deployed within a blood vessel, adjacent the vascular malformation. The second section is configured to form a second coil, circumferentially lining a wall of the blood vessel. Other embodiments are also described.

Claims (28)

1 . A non-occlusive blood restricting device for delivery by a microcatheter and for treating a vascular malformation, the blood restricting device comprising a wire comprising:

a first section configured to be coiled into a first coil when deployed within the vascular malformation; wherein said first coil comprises a spiral or sequence of loops, said spiral or sequence of loops having a gradually decreasing diameter; and wherein said first coil is configured to line a neck, a wall, or the neck and the wall of the vascular malformation so as to at least partially cover an orifice of the vascular malformation; and

a second section configured to be deployed within a blood vessel, adjacent the vascular malformation; wherein said second section is configured to form a second coil, circumferentially lining a wall of the blood vessel.

2 . The device of claim 1 , wherein said first section is essentially perpendicular to said second section when not restrained.

3 . The device of claim 1 , further comprising an intermediate section, said intermediate section spacing apart said first and second spirals.

4 . The device of claim 1 , wherein said first coil has a form of a bowl when not restrained.

5 . The device of claim 1 , wherein said first coil has a form of a flat plate, when not restrained.

6 . The device of claim 1 , wherein a distal free end of said first section forms an outermost loop of said first coil and a proximal end of said first section forms an innermost loop of said first coil.

7 . The device of claim 1 , wherein a force exerted by said first section on the microcatheter configured to deliver said device to the blood vessel is gradually changing along a length of said first section.

8 . The device of claim 7 , wherein the force exerted on the microcatheter by a distal free end of said first section is weaker than the force exerted on the microcatheter by a proximal part of said first section.

9 . The device of claim 7 , wherein the force exerted on the microcatheter by a distal free end of said first section is stronger than the force exerted on the microcatheter by a proximal part of said first section.

10 . The device of claim 1 , wherein a diameter of said wire at a distal free end of said first section is smaller than a diameter of said wire at a proximal part of said first section, such that said wire has a tapered shape at said first section thereof.

11 . The device of claim 1 , wherein a diameter of said wire at a distal free end of said first section is larger than a diameter of said wire at a proximal part of said first section, such that said wire has a tapered shape at said first section thereof.

12 . The device of claim 1 , wherein said first coil comprises an aperture essentially in a center thereof, said aperture configured to at least partially line the orifice of the vascular malformation.

13 . The device of claim 1 , wherein at least a part of said wire is a spring defining a primary wind, and wherein said first and said second sections of said wire define respective secondary winds.

14 . The device of claim 13 , further comprising a core wire threaded in a proximal part of said first section.

15 . The device of claim 14 , wherein said core wire is tapered having a smaller diameter at a distal end thereof compared to a diameter at a proximal part thereof.

16 . The device of claim 13 , further comprising an auxiliary wire threaded along at least a part of a length of said wire, said auxiliary wire configured to facilitate deployment of said device in the blood vessel and to be removed after or during the deployment.

17 . A kit comprising the device of claim 1 , the kit further comprising:

the microcatheter configured to deliver said non-occlusive blood restricting device to a target area.

18 . The device of claim 1 , wherein the vascular malformation is a cerebral aneurysm, and wherein said first section is configured to be coiled into the first coil when deployed within the cerebral aneurysm.

19 . A method for treating a vascular malformation, the method comprising:

providing a non-occlusive blood restricting device for treating the vascular malformation, the blood restricting device including a wire including:

a first section configured to be coiled into a first coil when deployed within the vascular malformation; wherein the first coil comprises a spiral or sequence of loops, the spiral or sequence of loops having a gradually decreasing diameter; and wherein the first coil is configured to line a neck, a wall, or the neck and the wall of the vascular malformation so as to at least partially cover an orifice of the vascular malformation, and

a second section configured to be deployed within a blood vessel, adjacent the vascular malformation; wherein the second section is configured to form a second coil, circumferentially lining a wall of the blood vessel; vessel, inserting, using a microcatheter, the non-occlusive blood restricting device into the blood vessel;

deploying the first section within the vascular malformation such that the first coil lines the neck, the wall, or the neck and the wall of the vascular malformation so as to at least partially cover the orifice of the vascular malformation; and

deploying the second section within the blood vessel such that the second section forms the second coil circumferentially lining the wall of the blood vessel.

20 . The method of claim 19 , wherein the vascular malformation is a cerebral aneurysm, and wherein deploying the first section within the vascular malformation comprises deploying the first section within the cerebral aneurysm.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 6, 2023
From: MAYER, DANEL; MAY, ALON
To: ENDOSTREAM MEDICAL LTD.
Reel/Frame 065778/0169 →
Continuity (5)
Continuation 16778581 · Jan 31, 2020
Continuation 15540664
Provisional Application 62098345 · Dec 31, 2014
Provisional Application 62216412 · Sep 10, 2015
Related Publication 20240108351A1 · Apr 4, 2024
References Cited (87)
US 5350397A · Palermo et al. · 1994 [cited by applicant]
US 5649949A · Wallace et al. · 1997 [cited by applicant]
US 5749891A · Ken et al. · 1998 [cited by applicant]
US 5935148A · Villar et al. · 1999 [cited by applicant]
US 6036720A · Abrams et al. · 2000 [cited by applicant]
US 6306141B1 · Jervis · 2001 [cited by applicant]
US 6338736B1 · Boosfeld et al. · 2002 [cited by applicant]
US 6371972B1 · Wallace et al. · 2002 [cited by applicant]
US 6383174B1 · Eder · 2002 [cited by applicant]
US 6428557B1 · Hilaire · 2002 [cited by applicant]
US 6506204B2 · Mazzochi · 2003 [cited by applicant]
US 6551305B2 · Ferrera et al. · 2003 [cited by applicant]
US 6589265B1 · Palmer et al. · 2003 [cited by applicant]
US 6740096B2 · Teague et al. · 2004 [cited by applicant]
US 6790218B2 · Jayaraman · 2004 [cited by examiner]
US 7128736B1 · Abrams et al. · 2006 [cited by applicant]
US 7229461B2 · Chin et al. · 2007 [cited by applicant]
US 7323000B2 · Monstdt et al. · 2008 [cited by applicant]
US 7377932B2 · Mitelberg et al. · 2008 [cited by applicant]
US 7569066B2 · Gerberding et al. · 2009 [cited by applicant]
US 8007509B2 · Buiser et al. · 2011 [cited by applicant]
US 8333796B2 · Tompkins et al. · 2012 [cited by applicant]
US 8444667B2 · Porter · 2013 [cited by applicant]
US 8518064B2 · Kurrus et al. · 2013 [cited by applicant]
US 8570343B2 · Halstead · 2013 [cited by applicant]
US 8747454B2 · Khairkhahan et al. · 2014 [cited by applicant]
US 8764772B2 · Tekulve · 2014 [cited by applicant]
US 8906057B2 · Connor et al. · 2014 [cited by applicant]
US 9138232B2 · Connor · 2015 [cited by applicant]
US 9629635B2 · Hewitt et al. · 2017 [cited by applicant]
US 10869673B2 · Zhang et al. · 2020 [cited by applicant]
US 11484322B2 · Connor · 2022 [cited by applicant]
US 20020049468A1 · Streeter et al. · 2002 [cited by applicant]
US 20020107534A1 · Schaefer et al. · 2002 [cited by applicant]
US 20020169473A1 · Sepetka et al. · 2002 [cited by applicant]
US 20030055451A1 · Jones et al. · 2003 [cited by applicant]
US 20030216772A1 · Konya et al. · 2003 [cited by applicant]
US 20040034386A1 · Fulton et al. · 2004 [cited by applicant]
US 20040098027A1 · Teoh et al. · 2004 [cited by applicant]
US 20040167597A1 · Costantino et al. · 2004 [cited by applicant]
US 20050038460A1 · Jayaraman · 2005 [cited by applicant]
US 20050107823A1 · Leone et al. · 2005 [cited by applicant]
US 20050187564A1 · Jayaraman · 2005 [cited by applicant]
US 20060155323A1 · Porter et al. · 2006 [cited by applicant]
US 20060206199A1 · Churchwell et al. · 2006 [cited by applicant]
US 20070083230A1 · Javois · 2007 [cited by applicant]
US 20070123928A1 · Farnan · 2007 [cited by examiner]
US 20070150045A1 · Ferrera · 2007 [cited by applicant]
US 20080114436A1 · Dieck et al. · 2008 [cited by applicant]
US 20080300616A1 · Que et al. · 2008 [cited by applicant]
US 20090099647A1 · Glimsdale et al. · 2009 [cited by applicant]
US 20090216265A1 · DeVries et al. · 2009 [cited by applicant]
US 20100121350A1 · Mirigian · 2010 [cited by applicant]
US 20110022149A1 · Cox et al. · 2011 [cited by applicant]
US 20120071911A1 · Sadasivan et al. · 2012 [cited by applicant]
US 20120143237A1 · Cam et al. · 2012 [cited by applicant]
US 20130296917A1 · Rees · 2013 [cited by applicant]
US 20140180377A1 · Bose et al. · 2014 [cited by applicant]
US 20140277095A1 · Kerr · 2014 [cited by applicant]
US 20160022445A1 · Ruvalcaba et al. · 2016 [cited by applicant]
US 20160120551A1 · Connor · 2016 [cited by applicant]
US 20170086851A1 · Wallace et al. · 2017 [cited by applicant]
US 20170135701A1 · Beckham et al. · 2017 [cited by applicant]
US 20170150971A1 · Hines · 2017 [cited by applicant]
US 20170333678A1 · Bowman et al. · 2017 [cited by applicant]
CN 202136073 · 2012 [cited by applicant]
CN 203787320 · 2014 [cited by applicant]
EP 0765636A2 · 1997 [cited by applicant]
WO 9525480A1 · 1995 [cited by applicant]
WO 2012158883A1 · 2012 [cited by applicant]
WO 2014165256 · 2014 [cited by applicant]
Medtronic EV3 Axium Youtube excerpts downloaded Aug. 13, 2018. [cited by applicant]
International Search Report of PCT/IL2015/051271 Completed Apr. 19, 2016, Mailed Apr. 19, 2016, 5 pages. [cited by applicant]
A Non-Final Office Action issued in U.S. Appl. No. 16/311,744, dated Sep. 2, 2020. [cited by applicant]
Nit-Occlud PDA, pfm medical (Jun. 2012). [cited by applicant]
Non-Final Office Action dated Oct. 21, 2019, issued in U.S. Appl. No. 15/540,664. [cited by applicant]
A Communication pursuant to Article 94(3) EPC in European Appl. No. 17814898.7, dated Oct. 5, 2020. [cited by applicant]
An extended European Search Report issued in European Appl. No. 17814898.7, dated Feb. 3, 2020. [cited by applicant]
Written Opinion of PCT/IL2015/051271 Completed Apr. 19, 2016, Mailed Apr. 19, 2016, 6 pages. [cited by applicant]
Translation of 1st Office Action in Chinese Appl. No. 201780051968.9, dated Jun. 2, 2020. [cited by applicant]
An International Search Report and a Written Opinion both dated Oct. 3, 2017, which issued during the prosecution of Applicant's PCT/IL2017/050694. [cited by applicant]
An Invitation to Pay Additional Fees in PCT/IL2019/051401, dated Mar. 30, 2020. [cited by applicant]
An International Search Report (ISR) and Written Opinion issued in PCT/IL2019/051401, dated Jun. 24, 2020. [cited by applicant]
Office Action dated Nov. 10, 2022 issued in U.S. Appl. No. 17/216,836. [cited by applicant]
A Non-Final Office Action dated Jan. 19, 2023 issued in U.S. Appl. No. 16/778,581. [cited by applicant]
A Non-Final Office Action dated Jun. 5, 2023 issued in U.S. Appl. No. 17/418,026. [cited by applicant]
A Final Office Action dated Dec. 19, 2023 issued in U.S. Appl. No. 17/418,026. [cited by applicant]